ВЛИЯНИЕ НАРУШЕНИЯ ФУНКЦИИ ЯИЧНИКОВ И ВАЖНОСТЬ ЗАМЕСТИТЕЛЬНОЙ ГОРМОНАЛЬНОЙ ТЕРАПИИ ПРИ ПРОТЕЗИРОВАНИИ ЗУБНЫХ РЯДОВ У ЖЕНЩИН В ПЕРИОД КЛИМАКСА (ОБЗОР ЛИТЕРАТУРЫ)
Аннотация
Библиографические ссылки
Сухих Г.Т., Сметник В.П., Андреева Е.Н., Балан В.Е., Гависова А.А., Григорян О.Р. и др. Менопаузальная гормонотерапия и сохранение здоровья женщин в зрелом возрасте. Проблемы репродукции. 2018;24(S6):727–756. Режим доступа: https://www.elibrary.ru/item. asp?id=37337274.
Цориев Т.Т., Дзеранова Л.К. и др. Краткое изложение проекта федеральных клинических рекомендаций по остеопорозу. Остеопороз и остеопатии. 2020;23(2):4–21. Режим доступа: https://www.osteo-endojournals. ru/jour/article/view/12373.
Kanis J.A., Cooper C., Rizzoli R., Reginster J.Y. European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women. Osteoporos Int. 2019;30(1):3–44. https://doi.org/10.1007/s00198- 018-4704-5.
Camacho P.M., Petak S.M., Binkley N., Clarke B.L., Harris S.T., Hurley D.L. et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis – 2016. Endocr Pract. 2016;22(Suppl 4):1–42. https://doi.org/10.4158/EP161435.GL.
Burns E.R., Stevens J.A., Lee R. The Direct Costs of Fatal and Non-Fatal Falls among Older Adults – United States. J Safety Res. 2016;58:99–103. https://doi.org/10.1016/j.jsr.2016.05.001.
Coyle D. Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada. MDM Policy Pract. 2019;4(1):2381468318818843. https://doi.org/10.1177/2381468318818843.
Skjødt M.K., Khalid S., Ernst M., Rubin K.H., Martinez-Laguna D., Delmestri A. et al. Secular Trends in the Initiation of Therapy in Secondary Fracture Prevention in Europe: A Multi-National Cohort Study including Data from Denmark, Catalonia, and the United Kingdom. Osteoporos Int. 2020;31(8):1535–1544. https://doi.org/10.1007/s00198-020-05358-4.
Johannesdottir F., Thrall E., Muller J., Keaveny T.M., Kopperdahl D.L., Bouxsein M.L. Comparison of Non-Invasive Assessments of Strength of the Proximal Femur. Bone. 2017;105:93–102. https://doi.org/10.1016/j. bone.2017.07.023.
Xu S.Y., Shi P., Zhou R.M. Post-Menopausal Oestrogen Deficiency Induces Osteoblast Apoptosis via Regulating HOTAIR/miRNA-138 Signalling and Suppressing TIMP1 Expression. J Cell Mol Med. 2021;25(10):4572–4582. https://doi.org/10.1111/jcmm.16216.
23. Crandall C.J., Aragaki A., Cauley J.A., Manson J.E., LeBlanc E., Wallace R. et al. Associations of Menopausal Vasomotor Symptoms with Fracture Incidence. J Clin Endocrinol Metab. 2015;100(2):524–534. https://doi. org/10.1210/jc.2014-3062. 10.
Tuomikoski P., Ylikorkala O., Mikkola T.S. Postmenopausal Hot Flushes and Bone Mineral Density: A Longitudinal Study. Acta Obstet Gynecol Scand. 2015;94(2):198–203. https://doi.org/10.1111/aogs.12546.
Wong E.M.M., Tomlinson G., Pinto M.M., Berger C., Cheung A.M., Prior J.C. Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos). Int J Environ Res Public Health. 2018;15(6):1079. https://doi.org/10.3390/ ijerph15061079.
Cosman F., de Beur S.J., LeBoff M.S., Lewiecki E.M., Tanner B., Randall S., Lindsay R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359–2381. https://doi.org/10.1007/s00198- 014-2794-2.
Jeremiah M.P., Unwin B.K., Greenawald M.H., Casiano V.E. Diagnosis and Management of Osteoporosis. Am Fam Physician. 2015;92(4):261–268. Available at: https://www.aafp.org/afp/2015/0815/p261.html.
